Search

Your search keyword '"Lazarevic I"' showing total 94 results

Search Constraints

Start Over You searched for: Author "Lazarevic I" Remove constraint Author: "Lazarevic I"
94 results on '"Lazarevic I"'

Search Results

6. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

7. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

8. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

11. IMMUNE-ESCAPE MUTATIONS AND STOP-CODONS IN HBSAG CIRCULATES IN A RELEVANT PROPORTION OF PATIENTS WITH CHRONIC HBV INFECTION EXPOSED TO ANTI-HBV DRUGS IN EUROPE: IMPLICATIONS FOR HBV TRANSMISSION IN THE SETTING OF VACCINATION AND DISEASE PROGRESSION

12. Combined analysis of the prevalence of drug-resistant Hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE)

13. IMMUNE-ESCAPE MUTATIONS AND STOP-CODONS IN HBSAG CIRCULATES IN A RELEVANT PROPORTION OF PATIENTS WITH CHRONIC HBV INFECTION EXPOSED TO ANTI-HBV DRUGS IN EUROPE: IMPLICATIONS FOR HBV TRANSMISSION IN THE SETTING OF VACCINATION AND DISEASE PROGRESSION

14. Immune-Escape Mutations and Stop-Codons in HBsAg Circulates in a Relevant Proportion of Patients with Chronic HBV Infection Exposed to Anti-HBV Drugs in Europe: Implications for HBV Transmission in the Setting of Vaccination and Disease Progression

15. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

17. THU-136 - Immune-Escape Mutations and Stop-Codons in HBsAg Circulates in a Relevant Proportion of Patients with Chronic HBV Infection Exposed to Anti-HBV Drugs in Europe: Implications for HBV Transmission in the Setting of Vaccination and Disease Progression

18. Significance of UGT1A1*28 genotype in patients with advanced liver injury caused by chronic hepatitis C

19. How to predict neurogenic pulmonary edema in aneurysmal subarachnoid hemorrhage?: Neurogenic pulmonary edema in aneurysmal SAH

21. Reshaping Clinical Trial Data Collection Process to Use the Advantages of the Web-Based Electronic Data Collection.

23. Intestinal parasitosis in asylum seekers from Middle East and South Asia

24. Respiratory syncytial virus infection and bronchial hyperreactivity in children up to two years of age in correlation with atopy

25. Analysis of the variability of Epstein-Barr virus genes in infectious mononucleosis: Investigation of the potential correlation with biochemical parameters of hepatic involvement

26. Design and analysis of the flat honeycomb sandwich structures

27. Failure investigation: Analysis procedure and some notable aircraft and aeroengine service failures

28. Genetic variability of the VP1 gene of BK and JC polyomaviruses in HIV-infected patients

29. The use of forests in the river Zagrža basin for the conservation of its hydrological and water protective function

30. Characteristics of Norovirus infection in Serbia

31. Distribution of macrolide-resistant genes among isolates of macrolideresistant Streptococcus pyogenes and Streptococcus pneumoniae in Serbia

32. Prevalence of JC and BK polyomavirus excretion in the urine of HIV-infected patients from Serbia

33. The role of single nucleotide polymorphisms of cytokine genes in viral infections

34. Prevalence and mutational patterns of lamivudine-resistant HBV strains in chronically infected Serbian patients

35. Prevalence of Epstein Barr Virus in biopsy specimens of nasopharyngeal carcinoma from Serbian patients

36. Possibilities of implementing progesterone EIA test in the control of reproduction in dairy cows

37. Complete genome sequences and phylogenetic analysis of Hepatitis B virus isolates from Serbia

38. The prevalence of human polyomaviruses in urine samples of immunocompetent individuals in the Serbian population

39. The prevalence of the most important viral infections in renal transplant recipients in Serbia

41. Oncogenic viruses and their role in tumor formation

42. Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe

43. Quantitative HBV Core Antibodies as a Prognostic Marker for HBeAg Seroclearance: A Systematic Review with Meta-Analysis.

44. Hepatitis B Surface Antigen Isoforms: Their Clinical Implications, Utilisation in Diagnosis, Prevention and New Antiviral Strategies.

45. Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus.

46. Uncovering the Role of Epstein-Barr Virus Infection Markers for Remission in Rheumatoid Arthritis.

47. Markers of Epstein-Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis: A Prospective Cohort Study.

50. Association of IL10RA , IL10RB , and IL22RA Polymorphisms/Haplotypes with Susceptibility to and Clinical Manifestations of SLE.

Catalog

Books, media, physical & digital resources